When the WHO director general privately 'lost patience' with China
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
You are now subscribed
Your newsletter sign-up was successful
World Health Organization Director General Tedros Adhanom Ghebreyesus was perhaps not as soft on China during the pandemic as was previously thought, according to The Washington Post, per reporting from the upcoming novel Aftershocks: Pandemic Politics and the End of the Old International Order.
The book, written by Thomas Wright and Colin Kahl, details how Ghebreyesus "cautiously praised China in public while pressuring it in private," and in fact even "lost patience" with the country for attempting to influence COVID-19 origin probes, the Post reports.
When a WHO team in China reportedly twice dismissed the lab leak theory as "extremely unlikely" and "unworthy of further investigation," Ghebreyesus pushed back on the results, maintaining that the research was not "extensive enough" and lacked "timely and comprehensive data-sharing," writes the Post, per Wright and Kahl. The investigative team was reportedly "defensive" in their response, and mentioned "pressure from Chinese officials that led to a compromise."
The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
And since then, relations between the two entities have "nosedived." When the WHO team's official findings, released in March, repeated the lab leak theory to be extremely unlikely, Ghebreyesus told China's envoy in Geneva that he would tell the truth about the report "even if China did not like it," per Wright and Kahl.
But Ghebreyesus' soft public posture toward China was at odds with the stance taken by the administration of former President Donald Trump, who Wright claims "undermined" the lab leak theory by "taking it too far." "That U.S.-China rivalry really shaped everything else," he said. Read more at The Washington Post.
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Brigid Kennedy worked at The Week from 2021 to 2023 as a staff writer, junior editor and then story editor, with an interest in U.S. politics, the economy and the music industry.
-
The environmental cost of GLP-1sThe explainer Producing the drugs is a dirty process
-
Nuuk becomes ground zero for Greenland’s diplomatic straitsIN THE SPOTLIGHT A flurry of new consular activity in the remote Danish protectorate shows how important Greenland has become to Europeans’ anxiety about American imperialism
-
‘This is something that happens all too often’Instant Opinion Opinion, comment and editorials of the day
-
A Nipah virus outbreak in India has brought back Covid-era surveillanceUnder the radar The disease can spread through animals and humans
-
Trump HHS slashes advised child vaccinationsSpeed Read In a widely condemned move, the CDC will now recommend that children get vaccinated against 11 communicable diseases, not 17
-
Covid-19 mRNA vaccines could help fight cancerUnder the radar They boost the immune system
-
FDA OKs generic abortion pill, riling the rightSpeed Read The drug in question is a generic version of mifepristone, used to carry out two-thirds of US abortions
-
The new Stratus Covid strain – and why it’s on the riseThe Explainer ‘No evidence’ new variant is more dangerous or that vaccines won’t work against it, say UK health experts
-
RFK Jr. vaccine panel advises restricting MMRV shotSpeed Read The committee voted to restrict access to a childhood vaccine against chickenpox
-
Texas declares end to measles outbreakSpeed Read The vaccine-preventable disease is still spreading in neighboring states, Mexico and Canada
-
RFK Jr. shuts down mRNA vaccine funding at agencySpeed Read The decision canceled or modified 22 projects, primarily for work on vaccines and therapeutics for respiratory viruses
